Results 271 to 280 of about 1,081,297 (374)

Rapid and Ultra‐Sensitive SARS‐CoV‐2 Subgenomic RNA Detection Using Single‐Molecule With a Large Transistor‐SiMoT Bioelectronic Platform

Advanced Electronic Materials, EarlyView.
The single‐molecule with a large transistor‐SiMoT is proposed for the detection of the subgenomic RNA of SARS‐CoV‐2, achieving a diagnostic sensitivity of 98.0% and a specificity of 87.8%. The SiMoT technology, currently at TRL‐5, is suitable for point‐of‐care settings and delivers the result to the end user in 30 min.
Eleonora Macchia, Anna Maria D'Erchia, Mariapia Caputo, Angelica Bianco, Claudia Leoni, Francesca Intranuovo, Cecilia Scandurra, Lucia Sarcina, Cinzia Di Franco, Paolo Bollella, Gaetano Scamarcio, Luisa Torsi, Graziano Pesole   +12 more
wiley   +1 more source

Immunogenicity and safety of the 15-valent pneumococcal conjugate vaccine, a systematic review and meta-analysis. [PDF]

NPJ Vaccines
Wagner G, Gartlehner G, Thaler K, Ledinger D, Feyertag J, Klerings I, Saif-Ur-Rahman KM, Devane D, Olsson K, Adel Ali K, Vygen-Bonnet S, Salo H, Zavadska D, Grgič Vitek M, Oona M, Cunney R, Tuerlinckx D, Kristensen Lomholt F, Sommer I.   +18 more
europepmc   +1 more source

Harnessing the Biological Responses Induced by Nanomaterials for Enhanced Cancer Therapy

Aggregate, EarlyView.
Nanomaterial (NM)‐induced toxicity can be strategically repurposed for cancer therapy. This review summarizes the mechanism by which NMs selectively activate specific cellular processes to regulate cell fate independently. We also discussed how NMs‐induced biological responses can be leveraged as therapeutic strategies for cancer treatment.
Liting Wang, Hao Fu, Jiangtao Lin, Meng Zhao, Chuanrong Chen, Hongze Liao, Yourong Duan   +6 more
wiley   +1 more source

Correction to: Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. [PDF]

Open Forum Infect Dis
europepmc   +1 more source

Five-Year Immune Persistence of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) and Immunogenicity and Safety of a Booster Dose in Children. [PDF]

Infect Dis Ther
Martinón-Torres F, Simko R, Ebert R, Rämet M, Zocchetti C, Syrkina O, Bchir S, Bertrand-Gerentes I.   +7 more
europepmc   +1 more source

Conjugate pneumococcal vaccine and antibiotic-resistant Streptococcus pneumoniae : herd immunity and reduction of otitis morbidity

, 2000
Ron Dagan, Drora Fraser
openalex   +1 more source

Safety, Tolerability and Immunogenicity of 15-valent Pneumococcal Conjugate Vaccine in Toddlers Previously Vaccinated With 7-valent Pneumococcal Conjugate Vaccine

The Pediatric Infectious Disease Journal, 2015
Ajoke Sobanjo-ter Meulen, T. Vesikari, Edgardo A Malacaman, S. Shapiro, M. Dallas, Patricia A Hoover, Richard D. McFetridge, J. Stek, Rocio D. Marchese, J. Hartzel, W. Watson, L. Musey   +11 more
semanticscholar   +1 more source

Supramolecular Assembly of Triterpenoids: Current State and Biomedical Perspectives

Aggregate, EarlyView.
Triterpenoids serve as both exceptional molecular motifs for supramolecular assembly and versatile therapeutic agents, offering broad biological functions to improve health outcomes and enhance treatment efficacy. This review comprehensively summarizes recent advances in triterpenoid‐based supramolecular systems, including their roles as functional ...
Jie Zhong, Juan C. Mareque‐Rivas, Xinmiao Lan, Yu‐Xiong Su   +3 more
wiley   +1 more source

Economic Evaluation of Transitioning to the 20-Valent Pneumococcal Conjugate Vaccine in the Dutch Paediatric National Immunisation Programme. [PDF]

Infect Dis Ther
Çakar E, Ta A, Peters M, Vinand E, Waterval-Overbeek A, Ilic A, Perdrizet J.   +6 more
europepmc   +1 more source

PHV15: CLINICAL AND ECONOMIC BENEFITS OF THE PNEUMOCOCCAL CONJUGATE VACCINE IN CHILDREN

, 2000
Gerry Oster, Derek Weycker, Vincent Ciuryla, Edward P. Richardson, Dorothea K. Thompson   +4 more
openalex   +1 more source